Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by Chefboy69on Feb 13, 2024 11:05am

89 Views

Post# 35877597

market cap?

moves up and down???

last week this stock was worth 30 million.

now 20 milllion??? lol

so illogical

the stock moves because traders manipulate it..THAT is the only reason

The movement of the share price HAS NOTHING TO DO WITH THE OPERATIONS OF THIS COMPANY

and has not for a long while!

<< Previous

Bullboard Posts

Next >>

Pembina reportedly in talks with Sinopec on LNG offtake agreement